Ovarian cancer: Why Australia could lead the world in the fight
Ovarian cancer is a ‘silent killer’, but it doesn’t have to be- and Australia could lead the way…
Scientists reveals how cancer-causing p53 mutations remain invisible to the immune system
One of the biggest challenges in cancer immunotherapy may not be that immune cells are too weak, but…
Immunotherapy shows potential for treating rising gynecological tumors
Gynecological tumors, including cervical cancer (CC), endometrial cancer (EC), and ovarian cancer (OC), represent a significant global health…
Special journal issue highlights precision prevention in cancer epidemiology
Cancer epidemiology is not merely about counting cases; it is a dynamic field that informs screening policies, resource…
Young Aussie diagnosed with ‘silent’ cancer in her 20s after bloating symptom
When Mikayla Hancock was taken to the emergency room at 9:50am on March 23, 2026, she didn’t expect…
Study links dietary fructose to aggressive spread of ovarian cancer
A new study from The Wistar Institute has uncovered an unexpected link between fructose – a common dietary…
US pharmaceutical giant Johnson & Johnson to pay out $7.9 billion over baby powder lawsuit
US pharmaceutical company Johnson & Johnson (J&J) has said it will pay an estimated $US5.5 billion ($7.9 billion)…
Wistar scientists develop new bispecific T cell engager to target ovarian cancer
Wistar scientists have developed a new type of bispecific T cell engager, or BTE, that is effective against…
Tennis world rallies around Chris Evert as legend misses Wimbledon after awful diagnosis
The tennis community is sending well-wishes and support to Chris Evert after the American legend announced she won’t…
BeOne Medicines (ONC): Citizens Sees an Inflection Point in Its Cancer Pipeline
BeOne Medicines AG (NASDAQ:ONC) is one of the most promising healthcare stocks according to Wall Street analysts. On…
University explores endometriosis and cancer link
Researchers at a university are exploring how endometriosis could influence the development of ovarian cancer and lead to…
MHC class II marks stronger immune response and longer survival in ovarian cancer
A new study sheds light on why some patients with the most aggressive form of ovarian cancer respond…